5 reports

Brodalumab is a novel human monoclonal antibody that binds to the interleukin-## (IL-##) receptor and inhibits inflammatory signaling by blocking the binding of several types of IL-## to the receptor.

  • Vitreoretinal Surgery Device
  • Northern Europe
  • United Kingdom
  • Abbott Medical Optics, Inc.
  • Alcon, Inc.

One unit refers to one reusable vitrectomy pack.

  • Ophthalmology
  • Vitreoretinal Surgery Device
  • North America
  • Market Size
  • Valeant Pharmaceuticals International, Inc.

One unit refers to one reusable vitrectomy pack.

  • Health Services
  • Vitreoretinal Surgery Device
  • Canada
  • Market Size
  • Valeant Pharmaceuticals International, Inc.

The entire contract includes several pharmaceuticals based of monoclonal antibodies produced in Russia by BIOCAD.

  • Healthcare
  • Vitreoretinal Surgery Device
  • North America
  • United States
  • Alcon, Inc.

Investment in research and development increased $## million, or ##%, to $## million in the first quarter of 2016, primarily due to the development programs related to the Company' s dermatology product portfolio, including IDP- ##, as well as brodalumab, an IL-## receptor monoclonal

  • Ophtalmic Surgery Device
  • Vitreoretinal Surgery Device
  • Canada
  • North America
  • Valeant Pharmaceuticals International, Inc.